XBI

State Street SPDR S&P Biotech ETF

$159.03

-5.25 (-3.20%)

AUM $10.93B

Expense Ratio 0.35%

NAV $160.52

Holdings 157

Asset Class Equity

Inception 01/30/2006

Provider SPDR

Top Holdings

1 APLS APELLIS PHARMACEUTICALS INC 1.82% 2 MRNA MODERNA INC 1.55% 3 APGE APOGEE THERAPEUTICS INC 1.45% 4 KYMR KYMERA THERAPEUTICS INC 1.36% 5 VKTX VIKING THERAPEUTICS INC 1.36% 6 ERAS ERASCA INC 1.23% 7 MIRM MIRUM PHARMACEUTICALS INC 1.22% 8 PRAX PRAXIS PRECISION MEDICINES I 1.21% 9 TWST TWIST BIOSCIENCE CORP 1.20% 10 PCVX VAXCYTE INC 1.20%

Fund Description

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.